171 Oyster Point Boulevard
South San Francisco
About Surrozen, Inc.
Surrozen is an innovative biopharmaceutical startup founded by Drs. Chris Garcia, Roel Nusse, Calvin Kuo and Claudia Janda, world-leading scientists from Stanford University. The company is focused on harnessing the Wnt pathway to identify novel therapeutics for regenerative medicine, leveraging breakthrough insights from our founders in protein engineering, stem cell dynamics and fundamental Wnt biology. Funded by The Column Group, a leading biotech venture capital firm, Surrozen is poised for robust growth and offers a stimulating work environment, competitive compensation and benefits, and an attractive relocation policy.
4 articles with Surrozen, Inc.
urrozen, a preclinical-stage company advancing drug candidates that promote the repair and regeneration of human tissues, today announced two appointments to expand its leadership team. Craig Parker, a biotech industry veteran recently of Jazz Pharmaceuticals, has been appointed CEO, and Hans Clevers, M.D., Ph.D., professor of molecular genetics at the Hubrecht Institute, has been appointed scientific co-founder of Surrozen.
1/24/2018Headquartered in South San Francisco, Surrozen focuses on developing drugs by leveraging insights into the Wnt signaling pathway.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.